Angiopoietin-like 3 in lipoprotein metabolism
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
http://www.nature.com/articles/nrendo.2017.119.pdf
Reference80 articles.
1. Bonanni, L., Cutolo, A. & Dalla Vestra, M. Novel approaches for the treatment of familial hypercholesterolemia. Exp. Clin. Endocrinol. Diabetes 124, 583–587 (2016).
2. Banach, M. et al. Statin intolerance — an attempt at a unified definition. Position paper from an international lipid expert panel. Expert Opin. Drug Saf. 14, 935–955 (2015).
3. Orringer, C. E. et al. Update on the use of PCSK9 inhibitors in adults: recommendations from an expert panel of the National Lipid Association. J. Clin. Lipidol. 4, 880–890 (2017).
4. Mattijssen, F. & Kersten, S. Regulation of triglyceride metabolism by angiopoietin-like proteins. Biochim. Biophys. Acta 1821, 782–789 (2012).
5. Conklin, D. et al. Identification of a mammalian angiopoietin-related protein expressed specifically in liver. Genomics 62, 477–482 (1999).
Cited by 150 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Zodasiran, an RNAi Therapeutic Targeting ANGPTL3, for Mixed Hyperlipidemia;New England Journal of Medicine;2024-09-12
2. Emerging Trends and Innovations in the Treatment and Diagnosis of Atherosclerosis and Cardiovascular Disease: A Comprehensive Review towards Healthier Aging;Pharmaceutics;2024-08-03
3. Therapeutic Monoclonal Antibodies for Metabolic Disorders: Major Advancements and Future Perspectives;Current Atherosclerosis Reports;2024-07-15
4. ANGPTL3 as a therapeutic target for treating homozygous familial hypercholesterolaemia: a shot in the arm for evinacumab;European Heart Journal;2024-06-10
5. A Randomized, Open-Label, Phase I, Single-Dose Study of Antisense Oligonucleotide, Vupanorsen, in Chinese Adults with Elevated Triglycerides;Drugs in R&D;2024-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3